Rational design of potent sialidase-based inhibitors of influenza virus replication

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,642

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,537

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623

Influenza virus M2 protein has ion channel activity

Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90452-i · Cited by 1,230

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution

Varghese, J. N., Laver, W. G., & Colman, P. M. (1983) · Nature · doi:10.1038/303035a0 · Cited by 891

The molecular basis of the specific anti‐influenza action of amantadine.

Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 855

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate

Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 816

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

Colman, P. M., Varghese, J. N., & Laver, W. G. (1983) · Nature · doi:10.1038/303041a0 · Cited by 806

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 788

A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors

Henderson, P. J. F. (1972) · Biochemical Journal · doi:10.1042/bj1270321 · Cited by 524

Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents

Brouillette, W. J., Bajpai, S. N., Ali, S. M., Velu, S. E., Atigadda, V. R., Lommer, B. S., Finley, J. B., Luo, M., & Air, G. M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00271-2 · Cited by 28

Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1

Nishino, R., Ikeda, K., Hayakawa, T., Takahashi, T., Suzuki, T., & Sato, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.010 · Cited by 28

Antiviral treatment and prophylaxis of influenza in primary care: German recommendations

Wutzler, P., Kossow, K.-D., Lode, H. M., Ruf, B., Scholz, H., & Vogel, G. E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.05.009 · Cited by 27

Sialic Acids

Miyagi, T., & Yamaguchi, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00055-6 · Cited by 28

Scientific lessons from the first influenza pandemic of the 20th century

OXFORD, J. S., Lambkin‐Williams, R., Elliot, A. J., Daniels, R. S., Sefton, A. Y., & Gill, D. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.101 · Cited by 28

Inhibition of bacterial and viral sialidases by 3-fluoro-N-acetylneuraminic acid

HAGIWARA, T., Kijima‐Suda, I., Ido, T., Ohrui, H., & Tomita, K. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)00133-2 · Cited by 28

Site-directed structure generation by fragment-joining

Böhm, H. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174465 · Cited by 28

Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells

Oh, S., & Eichelberger, M. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7738-7744.2000 · Cited by 28

Large-Scale Production and Structural and Biophysical Characterizations of the Human Hepatitis B Virus Polymerase

Vörös, J., Urbanek, A., Rautureau, G. J. P., O'Connor, M., Fisher, H. C., Ashcroft, A. E., & Ferguson, N. (2014) · Journal of Virology · doi:10.1128/jvi.02575-13 · Cited by 27

Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design

Yuan, X., & Xu, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072105 · Cited by 28

One-Pot Three-Component Synthesis of Highly Substituted Piperidines Using 1-Methyl-2-Oxopyrrolidinium Hydrogen Sulfate

Sajadikhah, S. S., Hazeri, N., Maghsoodlou, M. T., Habibi‐Khorassani, S. M., Beigbabaei, A., & Lashkari, M. (2012) · Journal of Chemical Research · doi:10.3184/174751912x13395258340271 · Cited by 27

A Glycotherapeutic Approach to Functionalize Biomaterials‐Based Systems

Gadekar, A., Bhowmick, S., & Pandit, A. S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910031 · Cited by 27

Analysis of the Results of Metadynamics Simulations by metadynminer and metadynminer3d

Trapl, D., & Spiwok, V. (2022) · The R Journal · doi:10.32614/rj-2022-057 · Cited by 27

Machine-Learning- and Knowledge-Based Scoring Functions Incorporating Ligand and Protein Fingerprints

Fujimoto, K. J., Minami, S., & Yanai, T. (2022) · ACS Omega · doi:10.1021/acsomega.2c02822 · Cited by 29

Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates

Terabayashi, T., Morita, M., Ueno, M., Nakamura, T., & Urashima, T. (2006) · Carbohydrate Research · doi:10.1016/j.carres.2006.06.017 · Cited by 27

Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors

Cohen, M., Senaati, H. P., Fisher, C., Huang, M. L., Gagneux, P., & Godula, K. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00191 · Cited by 27

Influenza Virus Sialidase - A Drug Discovery Target

von Itzstein, M. (2011) · Springer eBooks · doi:10.1007/978-3-7643-8927-7 · Cited by 27

Neuraminidase Inhibitors fromReynoutria elliptica

Chu-Hyun, L., Kim, S.-L., Lee, K., Yoo, Y., Ryu, S.-Y., & Song, K. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976693 · Cited by 27

Novel strategies for prevention and treatment of influenza

Kandel, R., & Hartshorn, K. L. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.1 · Cited by 27

Can drugs be designed?

Hubbard, R. E. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80122-x · Cited by 27

The promise of siRNAs for the treatment of influenza

Bennink, J. R., & Palmore, T. N. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.004 · Cited by 27

Synthesis and influenza virus sialidase inhibitory activity of the 5-desacetamido analogue of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid (GG167)

Starkey, I. D., Mahmoudian, M., Noble, D., Smith, P. W., Cherry, P. C., Howes, P. D., & Sollis, S. L. (1995) · Tetrahedron Letters · doi:10.1016/0040-4039(94)02235-4 · Cited by 27

Design of Aromatic Inhibitors of Influenza Virus Neuraminidase

Luo, M., Air, G. M., & Brouillette, W. J. (1997) · The Journal of Infectious Diseases · doi:10.1086/514178 · Cited by 27

Advances and Challenges in Antiviral Development for Respiratory Viruses

Jesús‐González, L. A. D., León‐Juárez, M., Lira-Hernández, F. I., Rivas-Santiago, B. T., Velázquez-Cervantes, M. A., Méndez-Delgado, I. M., Macias-Guerrero, D., Hernández-Castillo, J., Hernández-Rodríguez, X., Calderón-Sandate, D. N., et al. (2024) · Pathogens · doi:10.3390/pathogens14010020 · Cited by 27

Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors

Li, Y., Kong, Y., Zhang, M., Yan, A., & Liu, Z. (2016) · Molecular Informatics · doi:10.1002/minf.201500107 · Cited by 26

Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses

Hsu, P., Chiu, D.-C., Wu, K., Lee, P., Jan, J., Cheng, Y. E., Tsai, K., Cheng, T.-J. R., & Fang, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.030 · Cited by 26

Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1

Zima, V., Albiñana, C. B., Rojíková, K., Pokorná, J., Pachl, P., Řezáčová, P., Hudlicky, J. R., Navrátil, V., Majer, P., Konvalinka, J., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.024 · Cited by 26

Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic

Takahashi, J. A., Barbosa, B. V. R., Lima, M. T. N. S., Cardoso, P. G., Contigli, C., & Pimenta, L. P. S. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116366 · Cited by 29

Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges

Terrier, O., Si‐Tahar, M., Ducatez, M., Chevalier, C., Pizzorno, A., Goffic, R. L., Crépin, T., Simon, G., & Naffakh, N. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010106 · Cited by 28

Synthetic sialic-acid-containing polyvalent antiviral inhibitors

Cârlescu, I., Scutaru, D., Popa, M., & Uglea, C. V. (2008) · Medicinal Chemistry Research · doi:10.1007/s00044-008-9139-7 · Cited by 26

Combining docking, scoring and molecular field analyses to probe influenza neuraminidase–ligand interactions

Abuhammad, A., Afifi‐Yazar, F. Ü., & Taha, M. O. (2007) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.02.002 · Cited by 27

A novel approach to inhibit intracellular vitamin B 6 ‐dependent enzymes: proof of principle with human and plasmodium ornithine decarboxylase and human histidine decarboxylase

Wu, F., Christen, P., & Gehring, H. (2011) · The FASEB Journal · doi:10.1096/fj.10-174383 · Cited by 26

Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir

Sultana, I., Gao, J., Markoff, L. J., & Eichelberger, M. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.047 · Cited by 26

Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening

Ruggeri, C., Drinkwater, N., Sivaraman, K. K., Bamert, R. S., McGowan, S., & Paiardini, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138957 · Cited by 26

Ultrasensitive Fluorogenic Reagents for Neuraminidase Titration

Gao, Z., Niikura, M., & Withers, S. G. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610544 · Cited by 26

Current landscape and future prospects of antiviral drugs derived from microbial products

Takizawa, N., & Yamasaki, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.115 · Cited by 26

Structural and functional analysis of the hemagglutinin-esterase of infectious salmon anaemia virus

Müller, A., Markussen, T., Drabløs, F., Gjøen, T., Jørgensen, T. Ø., Solem, S. T., & Mjaaland, S. (2010) · Virus Research · doi:10.1016/j.virusres.2010.03.020 · Cited by 26

Novel linear polymers bearing thiosialosides as pendant-type epitopes for influenza neuraminidase inhibitors

Matsuoka, K., Takita, C., Koyama, T., Miyamoto, D., Yingsakmongkon, S., Hidari, K. I. P. J., Jampangern, W., Suzuki, T., Suzuki, Y., Hatano, K., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.016 · Cited by 26

Sialyloligosaccharides inhibit cholera toxin binding to the GM1 receptor

Sinclair, H. R., Smejkal, C. W., Glister, C., Kemp, F., van den Heuvel, E. G. H. M., de Slegte, J., Gibson, G. R., & Rastall, R. A. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.07.008 · Cited by 26

H5N1 avian influenza virus: an overview

Proença‐Módena, J. L., Macedo, I. S., & Arruda, E. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000100027 · Cited by 26

Antiviral Drugs (Other than Antiretrovirals)

Aoki, F. Y., Hayden, F. G., & Dolin, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00041-2 · Cited by 26

Interplay between influenza A virus and host factors: targets for antiviral intervention

Tripathi, S., Batra, J., & Lal, S. K. (2015) · Archives of Virology · doi:10.1007/s00705-015-2452-9 · Cited by 26

Structure-based drug design (SBDD): Every structure tells a story...

Reich, S., & Webber, S. E. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174536 · Cited by 26

A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1–N9 Neuraminidases: Insight into Neuraminidase–Inhibitor Interactions

Sriwilaijaroen, N., Magesh, S., Imamura, A., Ando, H., Ishida, H., Sakai, M., Ishitsubo, E., Hori, T., Moriya, S., Ishikawa, T., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01863 · Cited by 25

Towards materials discovery: assays for screening and study of chemical interactions of novel corrosion inhibitors in solution and coatings

White, P., Collis, G. E., Skidmore, M. A., Breedon, M., Ganther, W. D., & Venkatesan, K. (2020) · New Journal of Chemistry · doi:10.1039/c9nj06456g · Cited by 25

Searching for effective antiviral small molecules against influenza A virus: A patent review

Ginex, T., & Luque, F. J. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1831471 · Cited by 25

New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools

Arrué, L., Cigna-Méndez, A., Barbosa, T., Borrego-Muñoz, P., Struve-Villalobos, S., Oviedo, V., Martínez-García, C., Sepúlveda-Lara, A., Millán, N., Montesinos, J. C. E. M., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091914 · Cited by 28

Structure‐based design of anti‐infectives

Agarwal, A. K., & Fishwick, C. W. G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05859.x · Cited by 25

Design of N-acetyl-6-sulfo-β-d-glucosaminide-based inhibitors of influenza virus sialidase

Sasaki, K., Nishida, Y., Kambara, M., Uzawa, H., Takahashi, T., Suzuki, T., Suzuki, Y., & Kobayashi, K. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.01.013 · Cited by 25

Quantitative structure–activity relationship study of influenza virus neuraminidase A/PR/8/34 (H1N1) inhibitors by genetic algorithm feature selection and support vector regression

Cong, Y., Li, B.-K., Yang, X., Xue, Y. W., Chen, Y., & Zeng, Y. (2013) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2013.05.012 · Cited by 25

Synergistic effects in the designs of neuraminidase ligands: Analysis from docking and molecular dynamics studies

Yang, Z., Nie, Y., Yang, G., Zu, Y., Fu, Y., & Zhou, L. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.08.029 · Cited by 25

Development of an Antiviral Screening Protocol: One-Stone-Two-birds

Rumschlag-Booms, E., Zhang, H., Soejarto, D. D., Fong, H. H. S., & Rong, L. (2011) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000027 · Cited by 25

RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza

Young, D. C., Fowler, C. L., & Bush, K. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1004 · Cited by 26

The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles

Said, J., Trybala, E., Görander, S., Ekblad, M., Liljeqvist, J., Jennische, E., Lange, S., & Bergström, T. B. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02132-15 · Cited by 25

Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening

Weisshaar, M., Cox, R. M., Morehouse, Z. P., Kyasa, S. K., Yan, D., Oberacker, P., Mao, S., Golden, J. E., Lowen, A. C., Natchus, M. G., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00898-16 · Cited by 25

Animal models used to assess influenza antivirals

Mifsud, E. J., Tai, C. M. K., & Hurt, A. C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1540586 · Cited by 25

β-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase

Baragaña, B., McCarthy, O., Sánchez, P., Bosch‐Navarrete, C., Kaiser, M., Brun, R., Whittingham, J. L., Roberts, S. M., Zhou, X., Wilson, K. S., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.012 · Cited by 25

A drug targeting motif for glycosidase inhibitors: an iminosugar–boronate shows unexpectedly selective β-galactosidase inhibition

Johnson, L. L., & Houston, T. A. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(02)02196-2 · Cited by 25

Synthesis of 4-Azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A Key Intermediate for the Synthesis of GG167 from d -Glucono-δ-lactone

Liu, K., Shi, Y., Wu, Y., & Yao, Z. (2004) · Organic Letters · doi:10.1021/ol0491890 · Cited by 25

Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment

Gillissen, A., & Höffken, G. (2002) · Medical Microbiology and Immunology · doi:10.1007/s00430-002-0139-9 · Cited by 25

Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to l-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase

Brown, J. R., Nishimura, Y., & Esko, J. D. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.055 · Cited by 25

Loss of the N-Linked Glycan at Residue 173 of Human Parainfluenza Virus Type 1 Hemagglutinin-Neuraminidase Exposes a Second Receptor-Binding Site

Alymova, I. V., Taylor, G. L., Mishin, V. P., Watanabe, M., Murti, K. G., Boyd, K. L., Chand, P., Babu, Y. S., & Portner, A. (2008) · Journal of Virology · doi:10.1128/jvi.00474-08 · Cited by 25

Synthesis of a guanidino-sugar as a glycosyl cation mimic

Fotsch, C. H., & Wong, C. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73215-1 · Cited by 25

Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment

Kossyvakis, A., Mentis, A.-F. A., Tryfinopoulou, K., Pogka, V., Kalliaropoulos, A., Antalis, E., Lytras, T., Meijer, A., Tsiodras, S., Karakitsos, P., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2809-3 · Cited by 24

GRAIL: GRids of phArmacophore Interaction fieLds

Schuetz, D. A., Seidel, T., Garon, A., Martini, R., Körbel, M., Ecker, G. F., & Langer, T. (2018) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.8b00495 · Cited by 24

Electrochemical biosensing platform based on complex biantennary N-glycan for detecting enzymatic sialylation processes

Alshanski, I., Sukhran, Y., Mervinetsky, E., Unverzagt, C., Yitzchaik, S., & Hurevich, M. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112762 · Cited by 24

Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry

Worrall, E. E., Sudarisman, & Priadi, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.058 · Cited by 24

Recent progress and challenges in the discovery of new neuraminidase inhibitors

Chamni, S., & De‐Eknamkul, W. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.765861 · Cited by 24

Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone–sialic acid hybrids

Aoki, Y., Tanimoto, S., Takahashi, D., & Toshima, K. (2012) · Chemical Communications · doi:10.1039/c2cc38742e · Cited by 24

An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac

Kato, D., Kurebayashi, Y., Takahashi, T., Otsubo, T., Otake, H., Yamazaki, M., Chihiro, T., Minami, A., Ikeda, K., & Suzuki, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200761 · Cited by 24

Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors

Richard, M., Deléage, C., Barthélémy, M., Lin, Y. P., Hay, A. J., Lina, B., & Ferraris, O. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.021 · Cited by 24

Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia

Jancel, T., & Penzak, S. R. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.03.004 · Cited by 24

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors

Cheam, A. L., Barr, I., Hampson, A. W., Mosse, J., & Hurt, A. C. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.04.004 · Cited by 24

Structure–activity relationships in a series of C2-substituted gluco-configured tetrahydroimidazopyridines as β-glucosidase inhibitors

Li, T., Guo, L., Zhang, Y., Wang, J., Zhang, Z., Li, J., Zhang, W., Lin, J., Zhao, W. G., & Wang, P. G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.043 · Cited by 24

Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir)

Liu, Z., Wang, B., Zhao, L., Li, Y., Shao, H., Yi, H., You, X., & Li, Z. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.049 · Cited by 24

Experience with Oseltamivir in the Control of Nursing Home Influenza A Outbreak.

Shijubo, N., Yamada, G., Takahashi, M., Tokunoh, T., Suzuki, T., & Abe, S. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.366 · Cited by 23

Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor

Eichelberger, M. C., Prince, G. A., & Ottolini, M. G. (2004) · Virology · doi:10.1016/j.virol.2004.01.032 · Cited by 25

Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm

Hanessian, S., Wang, J., Montgomery, D., Stoll, V. S., Stewart, K. D., Kati, W. M., Maring, C. J., Kempf, D. J., Hutchins, C. W., & Laver, W. G. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00732-1 · Cited by 24

Synthesis of 2-Substituted Polyhydroxytetrahydropyrimidines ( N -Hydroxy Cyclic Guanidino-Sugars): Transition-State Mimics of Enzymatic Glycosidic Cleavage

Le, V., & Wong, C. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo9915574 · Cited by 24

The molecular basis of HIV capsid assembly

Jones, I. M., & Morikawa, Y. (1998) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199804/06)8:2 · Cited by 24

Synthetic oligosaccharides: recent advances

Boons, G. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)10031-3 · Cited by 24

Influenza Vaccines for the Elderly

Monto, A. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311212 · Cited by 24

Magnesium-Dependent RNA Binding to the PA Endonuclease Domain of the Avian Influenza Polymerase

Xiao, S., Klein, M. L., LeBard, D. N., Levine, B. G., Liang, H., MacDermaid, C. M., & Alfonso‐Prieto, M. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp408383g · Cited by 23

The conformational analysis and proton transfer of neuraminidase inhibitors: a theoretical study

Yang, Z., Yang, G., Zu, Y., Fu, Y., & Zhou, L. (2009) · Physical Chemistry Chemical Physics · doi:10.1039/b909299d · Cited by 23

Incorporating G-C Pair-Recognizing Guanidinium into PNAs for Sequence and Structure Specific Recognition of dsRNAs over dsDNAs and ssRNAs

Krishna, M. S., Wang, Z., Zheng, L., Bowry, J., Ong, A. A. L., Mu, Y., Prabakaran, M., & Chen, G. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00608 · Cited by 22

Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach

Paciotti, R., Agamennone, M., Coletti, C., & Storchi, L. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00306-0 · Cited by 23

Inhibition of influenza A virus sialidase activity by sulfatide

Suzuki, T., Takahashi, T., Nishinaka, D., Murakami, M., Fujii, S., Hidari, K. I. P. J., Miyamoto, D., Li, Y., & Suzuki, Y. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01045-7 · Cited by 23

A novel synthesis of chain-extended amino sugar derivatives through aza-Cope rearrangement of N-galactosyl-N-homoallylamines

Deloisy, S., & Kunz, H. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10720-1 · Cited by 23

Structural analysis of ricin and implications for inhibitor design

Robertus, J. D., Yan, X., Ernst, S. R., Monzingo, A. F., Worley, S., Day, P., Hollis, T., & Svinth, M. (1996) · Toxicon · doi:10.1016/s0041-0101(96)00103-1 · Cited by 23

Anwendung und Grenzen kristallographischer Daten im strukturbezogenen Liganden‐ und Wirkstoff‐Design

Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003) · Angewandte Chemie · doi:10.1002/ange.200200539 · Cited by 23

Generation of molecular diversity on N-acetyllactosamine via O-cyanomethyl ethers

Malet, C., & Hindsgaul, O. (1997) · Carbohydrate Research · doi:10.1016/s0008-6215(97)00142-0 · Cited by 23

Synthesis and Biological Evaluation of Sialylmimetics as Rotavirus Inhibitors

Fazli, A., Bradley, S. J., Kiefel, M. J., Jolly, C. L., Holmes, I. H., & von Itzstein, M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0100887 · Cited by 23

Combining machine learning and quantum mechanics yields more chemically aware molecular descriptors for medicinal chemistry applications

Tortorella, S., Carosati, E., Sorbi, G., Bocci, G., Cross, S., Cruciani, G., & Storchi, L. (2021) · Journal of Computational Chemistry · doi:10.1002/jcc.26737 · Cited by 22

Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors

Hong, B.-T., Chen, C., Fang, J., Tsai, K., Wang, S., Huang, W., Cheng, Y. E., & Wong, C. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.10.005 · Cited by 22

Competitive Fitness of Influenza B Viruses with Neuraminidase Inhibitor-Resistant Substitutions in a Coinfection Model of the Human Airway Epithelium

Burnham, A. J., Armstrong, J., Lowen, A. C., Webster, R. G., & Govorkova, E. A. (2015) · Journal of Virology · doi:10.1128/jvi.02473-14 · Cited by 22

Design, synthesis and biological evaluation of 3′-benzylated analogs of 3′-epi-neoponkoranol as potent α-glucosidase inhibitors

Liu, D., He, W., Wang, Z., Liu, L., Wang, C., Zhang, C., Wang, C., Wang, Y., Tanabe, G., Muraoka, O., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.029 · Cited by 22

Sialidase-Catalyzed One-Pot Multienzyme (OPME) Synthesis of Sialidase Transition-State Analogue Inhibitors

Xiao, A., Li, Y., Li, X., Santra, A., Yu, H., Li, W., & Chen, X. (2017) · ACS Catalysis · doi:10.1021/acscatal.7b03257 · Cited by 22

A Sulfonozanamivir Analogue Has Potent Anti‐influenza Virus Activity

Hadházi, Á., Li, L., Bailly, B., Maggioni, A., Martin, G., Dirr, L., Dyason, J. C., Thomson, R. J., Gao, G. F., Borbás, A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800092 · Cited by 22

Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design

Morency, L.-P., Gaudreault, F., & Najmanovich, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_18 · Cited by 24

Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus

Obul, M., Wang, X., Zhao, J., Li, G., Aisa, H. A., & Huang, G. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9840-5 · Cited by 22

Influenza Virus Sialidase - A Drug Discovery Target

von Itzstein, M. (2011) · Springer eBooks · doi:10.1007/978-3-7643-8927-7 · Cited by 27

Advances in influenza virus sialidase inhibitors

Niu, Y., Cao, X., & Ye, X. (2007) · Lanzhou University Institutional Repository · Cited by 1

Sialidase as a target for inhibitors of influenza virus replication

Bethell, R. C., & Smith, P. W. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.10.1501 · Cited by 11

Design and Synthesis of Sialidase Inhibitors for Influenza Virus Infections

Rich, J., Gehle, D., & von Itzstein, M. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00107-0 · Cited by 10

Sialidases: structures, biological significance and therapeutic potential

Taylor, G. L. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80014-5 · Cited by 223